Related Experiment Video
Updated: Aug 3, 2026
07:16
Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission
Published on: August 16, 2018
Glutamate receptor ligands as anxiolytics
E Chojnacka-Wójcik1, A Kłodzinska, A Pilc
1Institute of Pharmacology, Polish Academy of Sciences, Krakow, Smetna. wojcik@if-pan.krakow.pl
Current Opinion in Investigational Drugs (London, England : 2000)
|March 15, 2002
Summary
New research suggests metabotropic glutamate (mGlu) receptor ligands show promise as future anxiolytic drugs. These compounds may offer anxiety relief without the side effects associated with current treatments.
Area of Science:
- Neuroscience
- Pharmacology
- Anesthesiology
Background:
- The glutamatergic system is a key target for anxiolytic drug development.
- NMDA receptor antagonists show anxiolytic effects but have significant side effects.
- Glycine receptor modulators and AMPA/kainate receptors are also being investigated for anxiety treatment.
Purpose of the Study:
- To explore novel targets within the glutamatergic system for anxiolytic drug discovery.
- To evaluate the potential of metabotropic glutamate (mGlu) receptor ligands as next-generation anxiolytics.
- To identify anxiolytic agents with improved side-effect profiles compared to existing treatments.
Main Methods:
- Review of animal models of anxiety.
- Evaluation of NMDA receptor antagonists and glycine receptor modulators.
- Assessment of selective mGlu5 receptor antagonists (e.g., MPEP) and group II mGlu receptor agonists (e.g., LY-354740).
Main Results:
- MPEP, an mGlu5 antagonist, demonstrated anxiolytic-like effects in animal models with minimal side effects.
- LY-354740, a group II mGlu receptor agonist, produced marked anxiolytic-like effects, mild sedation, and no motor coordination impairment or dependence potential.
- Glutamatergic system modulation offers a promising avenue for developing safer anxiolytics.
Conclusions:
- mGlu receptor ligands represent a promising new class of anxiolytic drugs.
- These ligands may overcome the limitations and side effects associated with traditional anxiolytics like benzodiazepines.
- Further research into mGlu receptor modulation could lead to the development of effective and well-tolerated anxiety treatments.
More Related Videos
04:48A High-throughput Calcium-flux Assay to Study NMDA-receptors with Sensitivity to Glycine/D-serine and Glutamate
Published on: July 10, 2018
05:17BS3 Chemical Crosslinking Assay: Evaluating the Effect of Chronic Stress on Cell Surface GABAA Receptor Presentation in the Rodent Brain
Published on: May 26, 2023
Related Concept Videos
01:19Ligand-gated Ion Channels
Ligand-gated ion channels are transmembrane proteins with a channel for ions to pass through and a binding site for a ligand. The channel opens only when a ligand attaches to the binding site.
Three Subfamilies of Ligand-gated Ion Channels
Ligand-gated ion channels fall into three subfamilies. The 'Cys-loop' includes the nicotinic acetylcholine receptors, γ-aminobutyric acid (GABA), glycine, and 5-hydroxytryptamine receptors. The second one is the 'Pore-loop' channels that include the...
Three Subfamilies of Ligand-gated Ion Channels
Ligand-gated ion channels fall into three subfamilies. The 'Cys-loop' includes the nicotinic acetylcholine receptors, γ-aminobutyric acid (GABA), glycine, and 5-hydroxytryptamine receptors. The second one is the 'Pore-loop' channels that include the...
01:30Ligand-Gated Ion Channel Receptor: Gating Mechanism
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
01:26Anxiolytic Drugs: Overview
Anxiolytic drugs are vital in managing anxiety disorders by effectively alleviating symptoms such as excessive fear, tachycardia, and tremors. There are several classes of anxiolytic medications, each with unique mechanisms of action and potential side effects.
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic circuitry.
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic circuitry.
01:29Anxiolytic Drugs: Benzodiazepines and Buspirone
Benzodiazepines are a class of anxiolytic drugs known for their rapid efficacy and high therapeutic-to-lethal dose ratio, but with a potential risk of drug dependence. These drugs are lipophilic, allowing for rapid absorption after oral administration, eventually reaching the central nervous system (CNS). Once in the CNS, benzodiazepines bind to the allosteric site of the GABAA receptor. This binding enhances the inhibitory effects of the neurotransmitter GABA. By doing so, they prevent...
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
01:14Antiepileptic Drugs: Glutamate Antagonists
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...